Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice.

Kang ChenWei WeiLei LiuZhu-Jian DengLe LiXiu-Mei LiangPing-Ping GuoLu-Nan QiZhi-Ming ZhangWen-Feng GongShan HuangWei-Ping YuanLiang MaBang-De XiangLe-Qun LiJian-Hong Zhong

Published in: Cancer immunology, immunotherapy : CII (2021)

In this real-world study, lenvatinib combined with ICIs showed significantly promising efficacy and manageable safety than lenvatinib alone in patients with unresectable HCC.

Keyphrases

clinical practice
locally advanced
liver metastases